Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind Recommended Dose-finding Study of SI-6603 in Patients With Lumbar Disc Herniation (Phase II/III Study)

NCT00634946 is registered in ClinicalTrials.gov with Seikagaku Corporation as lead sponsor.

NCT NCT00634946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00634946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind Recommended Dose-finding Study of SI-6603 in Patients With Lumbar Disc Herniation (Phase II/III Study)
Lead sponsor
Seikagaku Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2008
Completion date
August 31, 2010
Enrollment
195 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar vertebra hernia